Comment from Mr Zhenggang He, Actual Controller - Sichuan Hebang Biotechnology Co., Ltd.:
“We have been working with the Avenira team for some time. We are interested in furthering our
collaborative relationship with Avenira by investing in the company and participating on the board
and management team. In the meantime, we are open to providing further financial and technical
support to ensure Avenira’s future growth and success.
We look forward to working with Brett and the Avenira team and contributing to the future success
of the company.
Count on it. Aleees, Hebang, N.T., AEV's other assets. MC $25 million. "A diamond in the dust". ST thinkers not required.
- Forums
- ASX - By Stock
- AEV
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
AEV
avenira limited
Add to My Watchlist
5.56%
!
1.0¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-25
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(5.56%) |
Mkt cap ! $30.18M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $1.134K | 114.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 4417742 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 7499710 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 4417742 | 0.009 |
9 | 6453820 | 0.008 |
8 | 5719060 | 0.007 |
4 | 1585000 | 0.006 |
1 | 400000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 7499710 | 14 |
0.011 | 1520099 | 3 |
0.012 | 2544954 | 2 |
0.013 | 1234269 | 4 |
0.014 | 571499 | 2 |
Last trade - 10.02am 25/06/2025 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online